Cambridge Investment Research Advisors, Inc. Ginkgo Bioworks Holdings, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$0.28 - $1.16 $1,040 - $4,310	-3,716 Reduced 9.71%	34,548 $12,000
Q1 2024 Apr 24, 2024	BUY	$1.06 - $1.67 $540 - $851	510 Added 1.35%	38,264 $44,000
Q4 2023 Feb 09, 2024	BUY	$1.26 - $1.79 $2,217 - $3,150	1,760 Added 4.89%	37,754 $64,000
Q3 2023 Oct 24, 2023	BUY	$1.61 - $2.54 $745 - $1,176	463 Added 1.3%	35,994 $65,000
Q2 2023 Jul 13, 2023	BUY	$1.14 - $1.95 $188 - $321	165 Added 0.47%	35,531 $66,000
Q1 2023 May 11, 2023	BUY	$1.2 - $2.19 $2,575 - $4,699	2,146 Added 6.46%	35,366 $47,000
Q4 2022 Feb 08, 2023	BUY	$1.63 - $3.52 $31,307 - $67,608	19,207 Added 137.07%	33,220 $56,000
Q3 2022 Oct 17, 2022	BUY	$0.73 - $3.74 $10,229 - $52,408	14,013 New	14,013 $43,000
Q2 2022 Jul 13, 2022	SELL	$2.2 - $4.2 $23,320 - $44,520	-10,600 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$2.83 - $8.69 $29,998 - $92,114	10,600 New	10,600 $42,000

Others Institutions Holding DNA

# of Institutions

Shares Held

48.1M

Call Options Held

Put Options Held

Black Rock Inc. New York, NY

42M
Shares

$429 Million
0.0% of portfolio
Titleist Asset Management, Ltd. San Antonio, TX

2.31M
Shares

$23.6 Million
0.92% of portfolio
Putnam Investments LLC Boston, MA

1.5M
Shares

$15.4 Million
0.0% of portfolio
Credit Suisse Ag Zurich, V8

1.15M
Shares

$11.7 Million
0.0% of portfolio
Benjamin F. Edwards & Company, Inc. St. Louis, MO

235K
Shares

$2.4 Million
0.0% of portfolio

View Full List

About Ginkgo Bioworks Holdings, Inc.

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $13.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

More about DNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account